333 related articles for article (PubMed ID: 25313037)
41. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
[TBL] [Abstract][Full Text] [Related]
42. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.
Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC
Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496
[TBL] [Abstract][Full Text] [Related]
43. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.
Pang LY; Scott M; Hayward RL; Mohammed H; Whitelaw CB; Smith GC; Hupp TR
Cell Cycle; 2011 Mar; 10(6):932-50. PubMed ID: 21368573
[TBL] [Abstract][Full Text] [Related]
44. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
45. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
46. TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.
Maeda R; Tamashiro H; Takano K; Takahashi H; Suzuki H; Saito S; Kojima W; Adachi N; Ura K; Endo T; Tamura TA
J Biol Chem; 2017 Feb; 292(8):3201-3212. PubMed ID: 28082682
[TBL] [Abstract][Full Text] [Related]
47. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
48. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response.
Calzado MA; de la Vega L; Möller A; Bowtell DD; Schmitz ML
Nat Cell Biol; 2009 Jan; 11(1):85-91. PubMed ID: 19043406
[TBL] [Abstract][Full Text] [Related]
49. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
[TBL] [Abstract][Full Text] [Related]
50. Mechanism of p53 stabilization by ATM after DNA damage.
Cheng Q; Chen J
Cell Cycle; 2010 Feb; 9(3):472-8. PubMed ID: 20081365
[TBL] [Abstract][Full Text] [Related]
51. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
Wang X
Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
[TBL] [Abstract][Full Text] [Related]
52. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
53. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
Burch LR; Scott M; Pohler E; Meek D; Hupp T
J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
[TBL] [Abstract][Full Text] [Related]
54. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
[TBL] [Abstract][Full Text] [Related]
55. Critical role for Daxx in regulating Mdm2.
Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
[TBL] [Abstract][Full Text] [Related]
56. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
[TBL] [Abstract][Full Text] [Related]
57. The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?
Meek DW; Hupp TR
Semin Cancer Biol; 2010 Feb; 20(1):19-28. PubMed ID: 19897041
[TBL] [Abstract][Full Text] [Related]
58. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
Hofmann TG; Stollberg N; Schmitz ML; Will H
Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
[TBL] [Abstract][Full Text] [Related]
59. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
[TBL] [Abstract][Full Text] [Related]
60. TRIM8 modulates p53 activity to dictate cell cycle arrest.
Caratozzolo MF; Micale L; Turturo MG; Cornacchia S; Fusco C; Marzano F; Augello B; D'Erchia AM; Guerrini L; Pesole G; Sbisà E; Merla G; Tullo A
Cell Cycle; 2012 Feb; 11(3):511-23. PubMed ID: 22262183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
